Hepatocellular carcinoma in elderly patients: challenges and solutions

References

• QuagliaATavillaAShackLThe cancer survival gap between elderly and middle-aged patients in Europe is wideningEur J Cancer20094561006101619121578
   PubMed Web of Science ®Google Scholar
• BoschFXRibesJDíazMClériesRPrimary liver cancer: Worldwide incidence and trendsGastroenterology20041275 Suppl 1S5S1615508102
   PubMed Web of Science ®Google Scholar
• AaproMSKöhneCHCohenHJExtermannMNever too old? Age should not be a barrier to enrollment in cancer clinical trialsOncologist200510319820415793223
   PubMed Web of Science ®Google Scholar
• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• XuXSChenWMiaoRCSurvival analysis of hepatocellular carcinoma: a comparison between young patients and aged patientsChin Med J (Engl)2015128131793180026112722
   PubMed Web of Science ®Google Scholar
• KondoKChijiiwaKFunagayamaMKaiMOtaniKOhuchidaJHepatic resection is justified for elderly patients with hepatocellular carcinomaWorld J Surg200832102223222918642042
   PubMed Web of Science ®Google Scholar
• PignataSGalloCDanieleBCharacteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly: A study of the Cancer of the Liver Italian Program (CLIP)Crit Rev Oncol Hematol200659324324916916608
   PubMed Web of Science ®Google Scholar
• OishiKItamotoTKohashiTMatsuguYNakaharaHKitamotoMSafety of hepatectomy for elderly patients with hepatocellular carcinomaWorld J Gastroenterol20142041150281503625386051
   PubMed Web of Science ®Google Scholar
• HuangJLiBKChenGHLong-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomyJ Gastrointest Surg20091391627163519506976
   PubMed Web of Science ®Google Scholar
• YauTYaoTJChanPThe outcomes of elderly patients with hepatocellular carcinoma treated with transarterial chemoembolizationCancer2009115235507551519701904
   PubMed Web of Science ®Google Scholar
• HiraokaAMichitakaKHoriikeNRadiofrequency ablation therapy for hepatocellular carcinoma in elderly patientsJ Gastroenterol Hepatol201025240340719929922
   PubMed Web of Science ®Google Scholar
• TakahashiHMizutaTKawazoeSEfficacy and safety of radiofrequency ablation for elderly hepatocellular carcinoma patientsHepatol Res20104010997100520887335
   PubMed Web of Science ®Google Scholar
• Mirici-CappaFGramenziASantiVTreatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experienceGut201059338739620207642
   PubMed Web of Science ®Google Scholar
• Liver EA for the S of the, Cancer EO for R and T of. EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinomaJ Hepatol201256490894322424438
   PubMed Web of Science ®Google Scholar
• NozawaAKuboSTakemuraSHepatic resection for hepatocellular carcinoma in super-elderly patients aged 80 years and older in the first decade of the 21st centurySurg Today201445785185725113072
   PubMed Web of Science ®Google Scholar
• DohmenKShirahamaMShigematsuHIrieKIshibashiHOptimal treatment strategy for elderly patients with hepatocellular carcinomaJ Gastroenterol Hepatol200419885986515242487
   PubMed Web of Science ®Google Scholar
• TalaricoLChenGPazdurREnrollment of elderly patients in clinical trials for cancer drug registration: A 7-year experience by the US Food and Drug AdministrationJ Clin Oncol200422224626463115542812
   PubMed Web of Science ®Google Scholar
• Frailty in older peopleLancet2013381986875276223395245
   PubMed Web of Science ®Google Scholar
• WelshTJGordonALGladmanJRComprehensive geriatric assessment – a guide for the non-specialistInt J Clin Pract201468329029324118661
   PubMed Web of Science ®Google Scholar
• StuckAESiuALWielandGDAdamsJRubensteinLZComprehensive geriatric assessment: a meta-analysis of controlled trialsLancet19933428878103210368105269
   PubMed Web of Science ®Google Scholar
• EllisGWhiteheadMAO’NeillDLanghornePRobinsonDComprehensive geriatric assessment for older adults admitted to hospitalCochrane Database Syst Rev20117CD00621121735403
   PubMed Web of Science ®Google Scholar
• DecosterLPuyveldeKVMohileSScreening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendationsAnn Oncol201526228830024936581
   PubMed Web of Science ®Google Scholar
• BelleraCARainfrayMMathoulin-PélissierSScreening older cancer patients: first evaluation of the G-8 geriatric screening toolAnn Oncol20122382166217222250183
   PubMed Web of Science ®Google Scholar
• KenisCDecosterLVan PuweldeKVPerformance of two geriatric screening tools in older patients with cancerJ Clin Oncol2014321192624276775
   PubMed Web of Science ®Google Scholar
• LiuuECanouï-PoitrineFTournigandCAccuracy of the G-8 geriatric-oncology screening tool for identifying vulnerable elderly patients with cancer according to tumour site: The ELCAPA-02 studyJ Geriatr Oncol201451111924484713
   PubMed Web of Science ®Google Scholar
• StokoeJMPearceJSinhaRRingAG8 and VES-13 scores predict chemotherapy toxicity in older patients with cancerJ Geriatr Oncol20123Suppl 1S81
   Google Scholar
• SoubeyranPBelleraCGoyardJValidation of the G8 screening tool in geriatric oncology: The ONCODAGE projectJ Clin Oncol20112915_Suppl9001
   Web of Science ®Google Scholar
• SalibaDElliottMRubensteinLZThe vulnerable elders survey: a tool for identifying vulnerable older people in the communityJ Am Geriatr Soc200149121691169911844005
   PubMed Web of Science ®Google Scholar
• HuismanMGAudisioRAUgoliniGScreening for predictors of adverse outcome in oncogeriatric surgical patients: A multicenter prospective cohort studyEur J Surg Oncol201541784485125935371
   PubMed Web of Science ®Google Scholar
• PottelLBoterbergTPottelHDetermination of an adequate screening tool for identification of vulnerable elderly head and neck cancer patients treated with radio(chemo)therapyJ Geriatr Oncol2012312432
   Web of Science ®Google Scholar
• HondaTMiyaakiHIchikawaTClinical characteristics of hepatocellular carcinoma in elderly patientsOncol Lett20112585185422866139
   PubMed Web of Science ®Google Scholar
• CohenMJBloomAIBarakOTrans-arterial chemo-embolization is safe and effective for very elderly patients with hepatocellular carcinomaWorld J Gastroenterol201319162521252823674854
   PubMed Web of Science ®Google Scholar
• KaoWYChiouYYHungHHYounger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapyJ Clin Gastroenterol2012461627021934530
   PubMed Web of Science ®Google Scholar
• SuCWLeiHJChauGYThe effect of age on the long-term prognosis of patients with hepatocellular carcinoma after resection surgery: A propensity score matching analysisArch Surg2012147213714422006855
   PubMedGoogle Scholar
• NishikawaHArimotoAWakasaTKitaRKimuraTOsakiYSurgical resection for hepatocellular carcinoma: clinical outcomes and safety in elderly patientsEur J Gastroenterol Hepatol201325891291923470356
   PubMed Web of Science ®Google Scholar
• ReddySKBarbasASTurleyRSMajor liver resection in elderly patients: a multi-institutional analysisJ Am Coll Surg2011212578779521435922
   PubMed Web of Science ®Google Scholar
• NishikawaHKimuraTKitaROsakiYTreatment for hepatocellular carcinoma in elderly patients: a literature reviewJ Cancer20134863564324155775
   PubMed Web of Science ®Google Scholar
• AlexiaCFallotGLasferMSchweizer-GroyerGGroyerAAn evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosisBiochem Pharmacol20046861003101515313394
   PubMed Web of Science ®Google Scholar
• van der PoortenDMilnerKLHuiJVisceral fat: A key mediator of steatohepatitis in metabolic liver diseaseHepatology200848244945718627003
   PubMed Web of Science ®Google Scholar
• Reduction of telomeric repeats as a possible predictor for development of hepatocellular carcinoma: Convenient evaluation by slot-blot analysisIsokawa2003Hepatology; Wiley Online Library Available from: http://onlinelibrary.wiley.com.passerelle.univ-rennes1.fr/doi/10.1002/hep.510300211/abstract?systemMessage=Wiley+Online+Library+will+have+intermittent+access+on+8th+August+2015+from+10%3A00-16%3A00+BST+%2F+05%3A00-11%3A00+EDT+%2F+17%3A00-23%3A00+SGT+for+essential+maintenance.++Apologies+for+the+inconvenienceAccessed August 7, 2015
   Google Scholar
• KeswaniRNAhmedAKeeffeEBOlder age and liver transplantation: A reviewLiver Transpl200410895796715390320
   PubMed Web of Science ®Google Scholar
• KimJKoMENelsonRAIncreasing age and survival after orthotopic liver transplantation for patients with hepatocellular cancerJ Am Coll Surg2014218343143824559955
   PubMed Web of Science ®Google Scholar
• IshizawaTMiseYAokiTSurgical technique: new advances for expanding indications and increasing safety in liver resection for HCCJ Hepatobiliary Pancreat Sci201017438939319924372
   PubMed Web of Science ®Google Scholar
• CesconMGraziGLDel GaudioMOutcome of right hepatectomies in patients older than 70 yearsArch Surg2003138554755212742961
   PubMedGoogle Scholar
• ShirabeKKajiyamaKHarimotoNEarly outcome following hepatic resection in patients older than 80 years of ageWorld J Surg20093391927193219603226
   PubMed Web of Science ®Google Scholar
• KaiboriMMatsuiKIshizakiMHepatic resection for hepatocellular carcinoma in the elderlyJ Surg Oncol200999315416019123236
   PubMed Web of Science ®Google Scholar
• FerreroAViganòLPolastriRHepatectomy as treatment of choice for hepatocellular carcinoma in elderly cirrhotic patientsWorld J Surg20052991101110516088422
   PubMed Web of Science ®Google Scholar
• NanashimaAAboTNonakaTPrognosis of patients with hepatocellular carcinoma after hepatic resection: Are elderly patients suitable for surgery?J Surg Oncol2011104328429121462192
   PubMed Web of Science ®Google Scholar
• YamadaSShimadaMMiyakeHOutcome of hepatectomy in super-elderly patients with hepatocellular carcinomaHepatol Res201242545445822295877
   PubMed Web of Science ®Google Scholar
• SulpiceLRayarMCampilloBAdvanced age remains an Achilles heel for liver resectionsWorld J Surg201338491892624337318
   PubMed Web of Science ®Google Scholar
• TateishiRShiinaSTerataniTPercutaneous radiofrequency ablation for hepatocellular carcinomaCancer200510361201120915690326
   PubMed Web of Science ®Google Scholar
• ShiinaSTateishiRAranoTRadiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factorsAm J Gastroenterol2012107456957722158026
   PubMed Web of Science ®Google Scholar
• De GiorgioMVezzoliSCohenEPrediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteriaLiver Transpl201016450351220373461
   PubMed Web of Science ®Google Scholar
• ThorntonRHCoveyAPetreENA comparison of outcomes from treating hepatocellular carcinoma by hepatic artery embolization in patients younger or older than 70 yearsCancer2009115215000500619642175
   PubMed Web of Science ®Google Scholar
• SatoMTateishiRYasunagaHMortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patientsJ Gastroenterol201247101125113322426637
   PubMed Web of Science ®Google Scholar
• NishikawaHKitaRKimuraTTranscatheter arterial chemoembolization for intermediate-stage hepatocellular carcinoma: clinical outcome and safety in elderly patientsJ Cancer20145759059725057310
   PubMed Web of Science ®Google Scholar
• MahvashAMurthyROdisioBCYttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinomaJ Hepatocell Carcinoma2016317
   Google Scholar
• HilgardPHamamiMFoulyAERadioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survivalHepatology20105251741174921038413
   PubMed Web of Science ®Google Scholar
• BruixJRaoulJLShermanMEfficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trialJ Hepatol201257482182922727733
   PubMed Web of Science ®Google Scholar
• LlovetJMRicciSMazzaferroVSorafenib in advanced hepatocellular carcinomaN Engl J Med2008359437839018650514
   PubMed Web of Science ®Google Scholar
• Di CostanzoGGTortoraRDe LucaMDImpact of age on toxicity and efficacy of sorafenib-targeted therapy in cirrhotic patients with hepatocellular carcinomaMed Oncol201330144623307255
   PubMed Web of Science ®Google Scholar
• WongHTangYFYaoTJThe outcomes and safety of single-agent sorafenib in the treatment of elderly patients with advanced hepatocellular carcinoma (HCC)Oncologist201116121721172822135121
   PubMed Web of Science ®Google Scholar
• JoMYasuiKKirishimaTEfficacy and safety of sorafenib in very elderly patients aged 80 years and older with advanced hepatocellular carcinomaHepatol Res201444131329133824528772
   PubMed Web of Science ®Google Scholar
• IavaroneMCabibboGPiscagliaFField-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multi-center study in ItalyHepatology20115462055206321898496
   PubMed Web of Science ®Google Scholar
• MorimotoMNumataKKondoMHigher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenibHepatol Res201141429630221348907
   PubMed Web of Science ®Google Scholar
• EdelineJCrouzetLLe SourdSSorafenib use in elderly patients with hepatocellular carcinoma: caution about use of platelet aggregation inhibitorsCancer Chemother Pharmacol201575121521925477009
   PubMed Web of Science ®Google Scholar
• Di CostanzoGGTortoraRDe LucaMImpact of age on toxicity and efficacy of sorafenib-targeted therapy in cirrhotic patients with hepatocellular carcinomaMed Oncol201330144623307255
   PubMed Web of Science ®Google Scholar